PAOG Expects Increased Visibility For Its CBD Nutraceuticals From USMJ Ecommerce Campaign
PAO Group, Inc. (OTC Pink: PAOG) announced its expectations for increased market visibility for its RX Branded CBD Nutraceuticals.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PAO Group, Inc. (OTC Pink: PAOG) announced its expectations for increased market visibility for its RX Branded CBD Nutraceuticals. This is attributed to the launch of the USMJ Ecommerce expansion campaign. PAOG currently markets its CBD products via North American Cannabis Inc.'s ecommerce site. The company is also collaborating with Puration, Inc. to develop additional CBD Nutraceuticals. Notably, PAOG holds a U.S. Patent for a cannabis extraction process and is working on a CBD formulation for Chronic Obstructive Pulmonary Disease (COPD) under the brand name RespRx.
Positive
- Expected increased market visibility for RX Branded CBD Nutraceuticals due to USMJ Ecommerce expansion.
- Collaboration with Puration, Inc. for additional CBD nutraceutical product development.
- Ownership of a U.S. Patent (No. 9,199,960) for a unique cannabis extraction method.
- Development of a CBD formulation specifically targeting symptoms of COPD.
Negative
- None.
Details
News Market Reaction – PAOG
The recorded move for PAOG in the trading session of this news was +5.00%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Sandusky, OH, Feb. 03, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company expects to enjoy increased market visibility for its RX Branded CBD Nutraceuticals resulting from the kickoff of the USMJ Ecommerce expansion campaign announced earlier today.
PAOG currently markets its own independent line of CBD nutraceutical products under its “RX” label available for sale on North American Cannabis Inc.’s (OTC Pink: USMJ) ecommerce site www.usmj.com.
PAOG is also working with Puration, Inc. (OTC Pink: PURA) on the development of additional CBD nutraceuticals products under PURA’s Farmersville Hemp brand.
PAOG owns intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960).
PAOG is developing both pharmaceutical and nutraceutical treatments for humans based on this intellectual property.
PAOG’s CBD formulation, derived from a patented cannabis extraction process, is years in the making for the treatment of symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions. PAOG is developing the CBD formulation with the intent of delivering an approved pharmaceutical treatment under the brand name RespRx.
For more information on Puration, visit http://www.purationinc.com
Learn more about PAOG at www.paogroupinc.com.
Disclaimer:
This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.
For More Information Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
Jim DiPrima
888-272-6472
info@pao.group
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.